# The APOLO Study: A Cross-Sectional Analysis of Disease Characteristics and Patient Burden in Moderate-to-Severe Atopic Dermatitis in Portugal

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/the-apolo-study-a-cross-sectional-analysis-of-disease-characteristics-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Bruno Kosa Lino Duarte,Pedro Mendes‐Bastos,Joana Antunes,Filomena Azevedo,Margarida Gonçalo,Martinha Henrique,Vanda Marques,Isabel Freitas,Tiago Torres |
| Citations | 1 |
| DOI | 10.1007/s13555-025-01347-9 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://link.springer.com/content/pdf/10.1007/s13555-025-01347-9.pdf |
| OpenAlex ID | https://openalex.org/W4407304329 |
| PMID | 39930312 |
| Type | article |
| Year | 2025 |

## Paper authors

- [Pedro Mendes‐Bastos](https://scholariq.org/researchers/pedro-mendes-bastos/)
- [Margarida Gonçalo](https://scholariq.org/researchers/margarida-goncalo/)
- [Isabel Freitas](https://scholariq.org/researchers/isabel-freitas/)
- [Filomena Azevedo](https://scholariq.org/researchers/filomena-azevedo/)
- [Tiago Torres](https://scholariq.org/researchers/tiago-torres/)

## Paper funders

- [Pfizer](https://scholariq.org/funders/pfizer/)
- [Sanofi](https://scholariq.org/funders/sanofi/)
- [Regeneron Pharmaceuticals](https://scholariq.org/funders/regeneron-pharmaceuticals/)

## Paper journal

- [Dermatology and Therapy](https://scholariq.org/journals/dermatology-and-therapy/)

## Paper primary topic

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)

## Paper topics

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Urticaria and Related Conditions](https://scholariq.org/topics/urticaria-and-related-conditions/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.